Citadel Advisors
GWPH

Citadel Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Citadel Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-39,800
Closed -$8.63M – 14962
2021
Q1 		$8.63M Sell
39,800
-32,500
-45% -$6.11M ﹤0.01% 3203
2020
Q4 		$8.34M Sell
72,300
-24,200
-25% -$2.71M ﹤0.01% 2886
2020
Q3 		$9.39M Buy
96,500
+30,700
+47% +$3.53M ﹤0.01% 2362
2020
Q2 		$8.07M Sell
65,800
-6,300
-9% -$715K ﹤0.01% 2480
2020
Q1 		$6.31M Sell
72,100
-48,600
-40% -$5.15M ﹤0.01% 2424
2019
Q4 		$12.6M Sell
120,700
-44,300
-27% -$4.97M 0.01% 1961
2019
Q3 		$19M Buy
165,000
+21,500
+15% +$3.26M 0.01% 1524
2019
Q2 		$24.7M Sell
143,500
-25,100
-15% -$4.34M 0.01% 1230
2019
Q1 		$28.4M Buy
168,600
+56,200
+50% +$8.36M 0.01% 1063
2018
Q4 		$10.9M Sell
112,400
-59,200
-34% -$7.77M 0.01% 1804
2018
Q3 		$29.6M Buy
171,600
+46,400
+37% +$6.69M 0.01% 1091
2018
Q2 		$17.5M Buy
125,200
+58,500
+88% +$8.31M 0.01% 1418
2018
Q1 		$7.51M Buy
66,700
+14,900
+29% +$1.87M ﹤0.01% 2007
2017
Q4 		$6.84M Sell
51,800
-400
-0.8% -$47K ﹤0.01% 2119
2017
Q3 		$5.3M Buy
52,200
+13,200
+34% +$1.41M ﹤0.01% 2254
2017
Q2 		$3.91M Buy
39,000
+2,800
+8% +$301K ﹤0.01% 2379
2017
Q1 		$4.38M Sell
36,200
-28,700
-44% -$3.52M ﹤0.01% 2175
2016
Q4 		$7.25M Sell
64,900
-7,700
-11% -$927K 0.01% 1632
2016
Q3 		$9.64M Buy
72,600
+19,300
+36% +$1.84M 0.01% 1390
2016
Q2 		$4.88M Buy
+53,300
New +$4.49M 0.01% 1839

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Citadel Advisors's GWPH Position: Q2 2021 in Review

Citadel Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 250,719 shares — an estimated $54.4M sold.

Citadel Advisors first reported a position in GWPH in Q1 2014 and held it in 29 quarters. The position peaked at $160M in Q3 2018. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Citadel Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Citadel Advisors sold 250,719 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $54.4M.
  • Citadel Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and held it in 29 quarters.
  • Citadel Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $160M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.